Search Results - "Kamata, Wataru"

Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents by Sato, Shuku, Kamata, Wataru, Okada, Satomi, Tamai, Yotaro

“…Translocation t(4;14) is an independent prognostic factor for adverse outcome in multiple myeloma (MM). However, reports concerning the therapeutic effects of…”
Get full text

From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution by Wang, Devin, Kamata, Wataru, Ye, Fengxi, You, M. James

“…The simultaneous detection of BCR::ABL1 and JAK2 V617F was rarely reported and their clonal relationship and dynamic clonal shift were not characterized. Here,…”
Get full text

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report by Sato, Shuku, Kamata, Wataru, Fukaguchi, Kiyomitsu, Tsunoda, Shun, Kamio, Tadashi, Koyama, Hiroshi, Sugimoto, Hideyasu, Tamai, Yotaro

“…Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects…”
Get full text

Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia Areata by Tamai, Yotaro, Teshima, Shinichi, Tsunoda, Shun, Kamata, Wataru, Sato, Shuku

“…Myeloproliferative neoplasms (MPNs) are caused by genetic abnormalities in the stem cells and manifest with various systemic symptoms. Here, we describe a case…”
Get full text

Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report by Matsui, Kenji, Kamata, Wataru, Mochida, Yasuhiro, Ishioka, Kunihiro, Moriya, Hidekazu, Hidaka, Sumi, Ohtake, Takayasu, Tamai, Yotaro, Kobayashi, Shuzo

“…Aplastic anemia (AA) is a rare but fatal disorder characterized by pancytopenia due to bone marrow hypoplasia. Anti-glomerular basement membrane disease…”
Get full text

Plasmablastic myeloma initially presented with ascites by Sato, Shuku, Tsunoda, Shun, Kamata, Wataru, Tamai, Yotaro

“…This paper reports a case of a 56-year-old male with IgG lambda plasmablastic myeloma exhibiting multiple chromosomal abnormalities. The patient initially…”
Get more information

Insight from an autopsy in a patient with rapidly worsening heart failure due to amyloid light-chain cardiac amyloidosis: A case report by Yokoyama, Hiroaki, Shishido, Koki, Ito, Junko, Kamata, Wataru, Katoh, Nagaaki, Saito, Shigeru

“…Amyloid light-chain (AL) amyloidosis is a systemic disease characterized by the deposition of misfolded immunoglobulin light chain, causing organ failure, and…”
Get full text

Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma by Sato, Shuku, Tsunoda, Shun, Kawahigashi, Teiko, Kamata, Wataru, Tamai, Yotaro

“…High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard treatment for symptomatic multiple myeloma (MM) in patients…”
Get full text

Integrated Clinical Genotype-Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms by Ye, Matthew T, Zuo, Zhuang, Calin, Steliana, Ye, Fengxi, He, Hua, Kamata, Wataru, Yang, Yaling, You, M James

“…STAT3 is a key transcription factor that mediates cancer progression through phosphorylation or gain-of-function mutations. STAT3 activation in myeloid…”
Get full text

AML-278: Examination of Optimal Administration of Arsenic Trioxide in Continuous Renal Replacement Therapy During Acute Promyelocytic Leukemia Treatment by Kamata, Wataru, Tsunoda, Shun, Sato, Shuku, Tamai, Yotaro

“…Arsenic trioxide (ATO), a safe and effective treatment for acute promyelocytic leukemia (APL), has an effective plasma arsenic concentration (PAC) of 37.6–150…”
Get full text

Poster: AML-278: Examination of Optimal Administration of Arsenic Trioxide in Continuous Renal Replacement Therapy During Acute Promyelocytic Leukemia Treatment by Kamata, Wataru, Tsunoda, Shun, Sato, Shuku, Tamai, Yotaro

Get full text

JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report by Oda, Yasuhiro, Sato, Shuku, Kanbe, Emiko, Kamata, Wataru, Okada, Satomi, Tamai, Yotaro

“…Although essential thrombocythemia (ET) and immune thrombocytopenia (ITP) have different etiologies, 3 previous reports have described ET development in ITP…”
Get full text

CML-105: A Validation of Vascular Adverse Events Risk Assessment Method for Japanese CML Patients with Tyrosine Kinase Inhibitors by Kamata, Wataru, Sato, Shku, Tsunoda, Shun, Okada, Satomi, Tamai, Yotaro

“…Tyrosine kinase inhibitors (TKIs) have substantially improved the prognosis of chronic myeloid leukemia (CML). However, TKIs can cause serious vascular adverse…”
Get full text

Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology by Tomiyoshi, Katsumi, Wilson, Lydia J., Mourtada, Firas, Mourtada, Jennifer Sims, Namiki, Yuta, Kamata, Wataru, Yang, David J., Inoue, Tomio

“…Targeted radionuclide therapy (TRT) for internal pathway-directed treatment is a game changer for precision medicine. TRT improves tumor control while…”
Get full text

Abstract 5053: Clinicopathologic and molecular genetic features of STAT3-mutated myeloid neoplasms by Ye, Matthew T., Zuo, Zhuang, Calin, Steliana, Ye, Fengxi, He, Hua, Kamata, Wataru, You, M. James

“…STAT3 is a key transcription factor that can mediate cancer progression through phosphorylation or gain-of-function mutations. STAT3 mutations have been mainly…”
Get full text

Retrospective Study of Acute Kidney Injury Incidence in Patients with Newly Diagnosed Acute Promyelocytic Leukemia by Kamio, Tadashi, Koyama, Hiroshi, Fukaguchi, Kiyomitsu, Sato, Shuku, Kamata, Wataru, Okada, Satomi, Tamai, Yotaro

“…Purpose: Acute promyelocytic leukemia (APL) constitutes 5-10% of all cases of newly diagnosed acute myeloid leukemia. However, data on the epidemiology and…”
Get full text

Retrospective Study of Acute Kidney Injury Incidence in Patients with Newly Diagnosed Acute Promyelocytic Leukemia by Kamio, Tadashi, Koyama, Hiroshi, Fukaguchi, Kiyomitsu, Sato, Shuku, Kamata, Wataru, Okada, Satomi, Tamai, Yotaro

“…Acute promyelocytic leukemia (APL) constitutes 5-10% of all cases of newly diagnosed acute myeloid leukemia. However, data on the epidemiology and risk factors…”
Get full text

Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia Areata by Tamai, Yotaro, Teshima, Shinichi, Tsunoda, Shun, Kamata, Wataru, Sato, Shuku

Get full text

Insight from an autopsy in a patient with rapidly worsening heart failure due to amyloid light-chain cardiac amyloidosis: A case report by Yokoyama, Hiroaki, Shishido, Koki, Ito, Junko, Kamata, Wataru, Katoh, Nagaaki, Saito, Shigeru

Get full text